News | July 29, 2021
Astec Lifesciences 1FY22 consolidated PAT at Rs. 12.98 Cr
The company posted net profit of Rs.16.18 crores for the period ended June 30, 2020.
The company posted net profit of Rs.16.18 crores for the period ended June 30, 2020.
The company proposes to utilise the net proceeds from the fresh issue towards payment of outstanding purchase consideration
Strides Pharma Science reported total income of Rs.3367.29 crores during FY 2020-21
Eris Lifesciences has reported total income of Rs.1220.57 crores during the 12 months period ended March 31, 2021
The company reported total income of Rs.390.05 crores during the 12 months period ended March 31, 2021
The IPO comprises a fresh issue of up to Rs. 11,600 million and an offer for sale of up to 7,305,245 equity shares of Rs. 2 each of Glenmark Life Sciences by Glenmark Pharmaceuticals
For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms
Discussions are likely to centre on how the country can move up the pharmaceutical value chain
Surgeon Yuvaraja operates on a 55-year-old patient at Medical City Hospital Muscat
Scholarships, research grants and industry mentorship framework aim to strengthen India’s pharma R&D ecosystem
Subscribe To Our Newsletter & Stay Updated
